Our Products

The molecular diagnostic platform powering our detection kits has been validated on numerous pathogens and field-test on patient samples.

 

If you are looking for an innovative molecular diagnostic solution with minimal set up to answer your question, or if you want to partner with us, please contact us.​

​

What we provide

  • Highly programmable solution: we can prototype any diagnostic in just a few days

  • Highly reliable results: we are 98% accurate compared to PCR diagnostics

  • Highly specific tests: we are 100% specific and can detect down to single nucleotide mutation

  • Freeze-dried on paper: our diagnostics do not rely on the cold chain

  • Easy adoption: low set-up and small footprint for on-site testing

  • Testing capabilities 100% independent from the PCR supply chain

What you need

To use En Carta Diagnostics and perform RT-qPCR-level accuracy diagnostics, all you need is:

​

  • En Carta diagnostics kits

  • Pipettes

  • A heating plate reader

​

Our diagnostics can be performed on saliva or NP swabs, extracted by boiling method.

You can also use the extraction method of your choice.

SARS-CoV-2 Diagnostic

Our newest diagnostic kit has been developed to work with the simplest extractions and results are provided for 100 tests in less than 1 hour.

​

Contact us to know more

SARS-CoV-2 Variants of Concern Diagnostic

The VoC kit enables rapid screening of patient samples. As a second line test, our kit provides a sequencing-like solution, in all set-ups not equipped with NGS technology:

​

Zika virus Diagnostic (American strain)

Field tested in Latin America on 268 patient samples.

 

Tested against 7 closely related viruses (including the Zika virus African strain) we demonstrate: 

  • an accuracy of 98.51% (95 % CI, 96.22 – 99.59 %) compared to the CDC RT-qPCR protocol

  • a specificity of 100%.

From start to finish in less than 3.5 hours, we are ready to provide you with our solution.

Chikungunya virus Diagnostic

Filed tested on 65 patient samples

Tested against 8 closely related viruses we demonstrate: 

  • an accuracy of 98.46% (95 % CI, 91.72 – 99.96 %) compared to the gold-standard RT-qPCR.

  • a specificity of 100%.

We are ready to provide you with our solution.

Rapid Diagnostic Developement

If you are looking for an innovative molecular diagnostic solution with minimal setup to answer your needs, or if you want to partner with us, please contact us